Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)



Rating:

Share or cite this content

Citations should be made in the following way:
A. Sacreas (Leuven, Belgium). A role for the mesothelium in restrictive chronic lung allograft dysfunction?. 1993

Member's Comments

No comment yet.

Related content which might interest you: Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 The role of inflammation in chronic heart failure Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Hyperinflation correlates with poor exercise tolerance in recipients with advanced chronic lung allograft dysfunction Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Obstructive and restrictive pulmonary function defect after chronic GVHD and lung transplantation: a pathologist’s view Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016 Prediction of chronic lung allograft dysfunction: a systems medicine challenge Source: Eur Respir J 2014; 43: 689-693 Year: 2014 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Physiology of chronic lung allograft dysfunction: back to the future? Source: Eur Respir J , 49 (4)  1700187; DOI: 10.1183/13993003.00187-2017 Year: 2017 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation Source: International Congress 2016 – Mechanisms of disease Year: 2016 Current perspectives in epithelial cell injury and repair: consequences for epithelial functions Source: Eur Respir Rev 2005; 14: 126-130 Year: 2005 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 B cells drive iBALT formation in a mouse model of chronic lung allograft dysfunction Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018